Lantos tours local biotech firm, hears concerns

Officials with Monogram Biosciences say a number of legislative pressures are hindering their ability to recoup costs and attract the top talent they need to survive.

Monogram has spent the past seven years providing individualized drug combinations to HIV-positive patients, and hopes to expand its technology into treating various types of cancer, according to CEO William Young. Congressman Tom Lantos, D-San Mateo, visited the lab Wednesday and heard Young's concerns, which include low levels of reimbursement for diagnostic firms, legislators' increasing zeal to regulate the biotech market and the elimination of relationships between private biotech companies and researchers working for the National Institutes of Health.

“This is a cutting-edge company,” Lantos said in support of Monogram's mission. “I think there are enormous possibilities for this kind of individualized approach to medicine.”

As representative for San Mateo County and parts of San Francisco, Lantos said he keeps a close eye on the medical and biotech world. He is an avid supporter of embryonic stem-cell research and, in 2002, co-authored a bill that raised $3.3 billion to fight HIV/AIDS, malaria and tuberculosis.

During Wednesday's tour of Monogram's laboratories, Lantos asked what skills are required to land a job at a firm like Monogram.

Most clinicians have a state-issued clinical laboratory license or at least a bachelor of science degree, according to Linda Kiss, Director of Process Development. Because many clinicians are required to obtain a state license, it's difficult to attract top talent — a fact that may force some biotech firms to relocate to other parts of the country, according to Young.

With 150 biotech firms in South San Francisco alone, “the demand for scientifically trained people is an issue,” Young said. Some work full-time at one firm and part-time at another to fill the gaps, he added.

Although Lantos joked about a brief stint in medical school — one that lasted until he saw his first cadaver — his granddaughter has been diagnosed with a rare lung disorder, piquing his interest in the medical world, he said.

businessLocalScience & TechnologyScience and Technology

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

Health care workers would be the first group in the state to receive the COVID-19 vaccine. (Go Nakamura/Getty Images/TNS)
Hope on the way: Here’s what to know about California’s COVID-19 vaccine plan

The first batch of doses could hit the state as soon as early December

The Big Game was played Friday at Memorial Stadium in Berkeley. (Shutterstock)
Stanford blocks extra point to stun Cal, win 123rd Big Game 24-23

The 123rd edition of the Big Game featured a number of firsts.… Continue reading

Psilocybin magic mushrooms (Shutterstock)
‘Magic mushrooms’ moving into the mainstream

Efforts to decriminalize psychedelics could follow several different paths

The 2020 Census has concluded taking responses sooner than expected. (Courtesy photo)
What does California have to lose if undocumented immigrants are excluded from the census?

By Kim Bojórquez The Sacramento Bee If The U.S. Supreme Court rules… Continue reading

Those who stick around San Francisco on long holiday weekends can enjoy a slower pace, uncrowded streets and beloved institutions like cable cars. <ins>(Kevin Hume/S.F. Examiner)</ins>
These empty San Francisco streets: A holiday dream

We’re here because we can be, and because we have nowhere else to be

Most Read